MEDIPOST, Inc.
- Biotech or pharma, therapeutic R&D
MEDIPOST has launched the world’s first, regulatory-approved allogeneic stem cell product named CARTISTEM® for the treatment of knee Osteoarthritis.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}